Informaciones
Psiquiátricas
2014-n.º 216
29
APATÍA EN LA DEMENCIA. DE LA NEUROBIOLOGÍA A LA CLÍNICA
57. Brodaty H, Altendorf A, Withall A, Sach-
dev P. Do people become more apathetic
as they grow older? A longitudinal study
in healthy individuals. Int Psychogeriatr.
2010 May;22(3):426-36. doi: 10.1017/
S1041610209991335. Epub 2009 Dec
15.
58. Wetzels R, Zuidema S, Jansen I, Verhey
F, Koopmans R. Course of neuropsy-
chiatric symptoms in residents with
dementia in long-term care institutions:
a systematic review. Int Psychogeriatr.
2010 Nov;22(7):1040-53. doi: 10.1017/
S1041610210000918. Epub 2010 Aug 3.
Review.
59. Reedeker N, Bouwens JA, van Duijn
E, Giltay EJ, Roos RA, van der Mast
RC. Incidence, course, and predictors
of apathy in Huntington’s disea-
se: a two-year prospective study. J
Neuropsychiatry Clin Neurosci. 2011
Fall;23(4):434-41. doi: 10.1176/appi.
neuropsych.23.4.434.
60. Agüera-Ortiz LF, Gil-Ruiz N, Cruz-Orduña
I, Ramos-Garcia MI, Osorio-Suarez RM,
Valentí-Soler M, et al. Grupo UIPA-CA-
FRS. Creación de una escala de medición
de la apatía en pacientes con demencia
tipo Alzheimer institucionalizados: la
escala APADEM-NH-66. Psicogeriatría
2010; 2 (4): 207-219.
61. Agüera-Ortiz LF, Cruz-Orduña I, Ramos-
Garcia MI, Valentí-Soler M, Gil-Ruiz N,
Osorio-Suarez RM, et al. Proceso de
creación de la escala APADEM-NH para la
medición de la apatía en pacientes con
demencia institucionalizados. Psicoge-
riatria 2011; 3 (1): 29-36.
62. Agüera-Ortiz L, Gil-Ruiz N, Cruz-Orduña
I, Ramos-García I, Osorio RS, Valentí-So-
ler M, et al. A Novel Rating Scale for the
Measurement of Apathy in Institutionali-
zed Persons with Dementia: The APA-
DEM-NH. Am J Geriatr Psychiatry. 2013
Jul 17. doi:pii: S1064-7481(13)00137-1.
10.1016/j.jagp.2013.01.079. [Epub
ahead of print]
63. Assal F, Cummings JL. Neuropsychiatric
symptoms in the dementias. Curr Opin
Neurol. 2002 Aug;15(4):445-50. Review.
64. Herrmann N, Rothenburg LS, Black
SE, Ryan M, Liu BA, Busto UE, et al.
Methylphenidate for the treatment of
apathy in Alzheimer disease: prediction
of response using dextroamphetamine
challenge. J Clin Psychopharmacol.
2008 Jun;28(3):296-301. doi: 10.1097/
JCP.0b013e318172b479.
65. Padala PR, Burke WJ, Shostrom VK,
Bhatia SC, Wengel SP, Potter JF, et al.
Methylphenidate for apathy and functio-
nal status in dementia of the Alzheimer
type. Am J Geriatr Psychiatry. 2010
Apr;18(4):371-4.
66. Drijgers RL, Aalten P, Winogrodzka
A, Verhey FR, Leentjens AF. Phar-
macological treatment of apathy
in neurodegenerative diseases: a
systematic review. Dement Geriatr
Cogn Disord. 2009;28(1):13-22. doi:
10.1159/000228840. Epub 2009 Jul 17.
Review.
67. Rodda J, Morgan S, Walker Z. Are
cholinesterase inhibitors effective in
the management of the behavioral and
psychological symptoms of dementia
in Alzheimer’s disease? A systematic
review of randomized, placebo-contro-
lled trials of donepezil, rivastigmine
and galantamine. Int Psychogeriatr.
